These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30030660)

  • 21. Anterior wall adenocarcinoma of bladder with similar clinicopathological and prognostic characteristics as common bladder carcinomas should not be treated as or classified into urachal adenocarcinomas.
    Zhou YW; Long YX; Song K; Liang LB; Cheng K; Chen Y; Liu JY
    Cancer Med; 2021 Aug; 10(16):5415-5428. PubMed ID: 34278741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associations between comorbidity, and overall survival and bladder cancer specific survival after radical cystectomy: results from the Alberta Urology Institute Radical Cystectomy database.
    Fairey AS; Jacobsen NE; Chetner MP; Mador DR; Metcalfe JB; Moore RB; Rourke KF; Todd GT; Venner PM; Voaklander DC; Estey EP
    J Urol; 2009 Jul; 182(1):85-92; discussion 93. PubMed ID: 19447413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of combined method in organ-sparing treatment of muscle-invasive bladder cancer recurrences.
    Startsev VY
    Arch Ital Urol Androl; 2002 Jun; 74(2):54-6. PubMed ID: 12161935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathology-based risk stratification of muscle-invasive bladder cancer patients undergoing cystectomy for persistent disease after induction chemoradiotherapy in bladder-sparing approaches.
    Koga F; Fujii Y; Masuda H; Numao N; Yokoyama M; Ishioka J; Saito K; Kawakami S; Kihara K
    BJU Int; 2012 Sep; 110(6 Pt B):E203-8. PubMed ID: 22289431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upstaging of nonurothelial histology in bladder cancer at the time of surgical treatment in the National Cancer Data Base.
    Cohen AJ; Packiam V; Nottingham C; Steinberg G; Smith ND; Patel S
    Urol Oncol; 2017 Jan; 35(1):34.e1-34.e8. PubMed ID: 27592529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Propensity matched comparative analysis of survival following chemoradiation or radical cystectomy for muscle-invasive bladder cancer.
    Ritch CR; Balise R; Prakash NS; Alonzo D; Almengo K; Alameddine M; Venkatramani V; Punnen S; Parekh DJ; Gonzalgo ML
    BJU Int; 2018 May; 121(5):745-751. PubMed ID: 29281848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative effectiveness of robot-assisted vs. open radical cystectomy.
    Hanna N; Leow JJ; Sun M; Friedlander DF; Seisen T; Abdollah F; Lipsitz SR; Menon M; Kibel AS; Bellmunt J; Choueiri TK; Trinh QD
    Urol Oncol; 2018 Mar; 36(3):88.e1-88.e9. PubMed ID: 29277584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Association between Mortality and Distance to Treatment Facility in Patients with Muscle Invasive Bladder Cancer.
    Ryan S; Serrell EC; Karabon P; Mills G; Hansen M; Hayn M; Menon M; Trinh QD; Abdollah F; Sammon JD
    J Urol; 2018 Feb; 199(2):424-429. PubMed ID: 29030318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radical Cystectomy
    Haque W; Verma V; Butler EB; Teh BS
    Anticancer Res; 2017 Oct; 37(10):5603-5608. PubMed ID: 28982876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlates of refusal of radical cystectomy in patients with muscle-invasive bladder cancer.
    Elshabrawy A; Wang H; Satsangi A; Wheeler K; Ramamurthy C; Pruthi D; Kaushik D; Liss M; Gelfond J; Fernandez R; Gore J; Svatek R; Mansour AM
    Urol Oncol; 2021 Apr; 39(4):236.e9-236.e20. PubMed ID: 33423936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Total cystectomy versus bladder preservation therapy for locally invasive bladder cancer: effect of combined therapy using balloon-occluded arterial infusion of anticancer agent and hemodialysis with concurrent radiation.
    Azuma H; Yamamoto K; Inamoto T; Ibuki N; Kotake Y; Sakamoto T; Kiyama S; Ubai T; Takahara K; Segawa N; Narumi Y; Katsuoka Y
    Am J Clin Oncol; 2009 Dec; 32(6):592-606. PubMed ID: 19593084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sociodemographic and survival disparities for histologic variants of bladder cancer.
    Jue JS; Koru-Sengul T; Moore KJ; Miao F; Alameddine M; Nahar B; Punnen S; Parekh DJ; Ritch CR; Gonzalgo ML
    Can J Urol; 2018 Feb; 25(1):9179-9185. PubMed ID: 29524972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of radical cystectomy for patients with invasive bladder cancer.
    Gore JL; Litwin MS; Lai J; Yano EM; Madison R; Setodji C; Adams JL; Saigal CS;
    J Natl Cancer Inst; 2010 Jun; 102(11):802-11. PubMed ID: 20400716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenocarcinoma of the urinary bladder.
    Gill HS; Dhillon HK; Woodhouse CR
    Br J Urol; 1989 Aug; 64(2):138-42. PubMed ID: 2765779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local control of muscle-invasive bladder cancer: preoperative radiotherapy and cystectomy versus cystectomy alone.
    Cole CJ; Pollack A; Zagars GK; Dinney CP; Swanson DA; von Eschenbach AC
    Int J Radiat Oncol Biol Phys; 1995 May; 32(2):331-40. PubMed ID: 7751174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Cancer of the Bladder Risk Assessment (COBRA) score: Estimating mortality after radical cystectomy.
    Welty CJ; Sanford TH; Wright JL; Carroll PR; Cooperberg MR; Meng MV; Porten SP
    Cancer; 2017 Dec; 123(23):4574-4582. PubMed ID: 28881475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contemporary treatment patterns and outcomes of sarcomatoid bladder cancer.
    Sui W; Matulay JT; Onyeji IC; Theofanides MC; James MB; RoyChoudhury A; Wenske S; DeCastro GJ
    World J Urol; 2017 Jul; 35(7):1055-1061. PubMed ID: 27803966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. External beam radiation therapy followed by interstitial radiotherapy with iridium-192 for solitary bladder tumours: results of 111 treated patients.
    van Onna IE; Oddens JR; Kok ET; van Moorselaar RJ; Bosch JL; Battermann JJ
    Eur Urol; 2009 Jul; 56(1):113-21. PubMed ID: 18722048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implications of Definitive Prostate Cancer Therapy on Soft Tissue Margins and Survival in Patients Undergoing Radical Cystectomy for Bladder Urothelial Cancer.
    Luchey AM; Lin HY; Yue B; Agarwal G; Gilbert SM; Lockhart J; Poch MA; Pow-Sang JM; Spiess PE; Sexton WJ
    J Urol; 2015 Nov; 194(5):1220-5. PubMed ID: 26055823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conditional survival after radical cystectomy for bladder cancer: evidence for a patient changing risk profile over time.
    Ploussard G; Shariat SF; Dragomir A; Kluth LA; Xylinas E; Masson-Lecomte A; Rieken M; Rink M; Matsumoto K; Kikuchi E; Klatte T; Boorjian SA; Lotan Y; Roghmann F; Fairey AS; Fradet Y; Black PC; Rendon R; Izawa J; Kassouf W
    Eur Urol; 2014 Aug; 66(2):361-70. PubMed ID: 24139235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.